Treatment of von Willebrand Disease

Pharmacology, Toxicology and Pharmaceutical Science

• Von Willebrand Disease 100%
• Von Willebrand Factor 85%
• Syndrome 57%
• Blood Clotting Factor 8 28%
• Blood Clotting Factor 8 Concentrate 28%
• Clinical Trial 14%
• Bleeding 14%
• Antifibrinolytic Agent 14%
• Bleeding Disorder 14%
• Recombinant Von Willebrand Factor 14%
• Desmopressin 14%

Keyphrases

• Von Willebrand Disease 100%
• Von Willebrand Factor 50%
• Plasma-derived 20%
• Factor VIII Concentrate 20%
• Developed Countries 10%
• Adjunct Therapy 10%
• Clinical Trials 10%
• Bleeding 10%
• Additional Treatment 10%
• Regulatory Approval 10%
• Desmopressin (DDAVP) 10%
• Inherited Bleeding Disorders 10%
• Von Willebrand Factor Deficiency 10%
• Antifibrinolytics 10%
• Von Willebrand Factor Concentrate 10%
• Marketing Approval 10%
• Recombinant Form 10%
• Congenital Von Willebrand Disease 10%